Zimmer Biomet Holdings, Inc.
ZBH
$100.91
$1.431.44%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.18B | 2.09B | 2.24B | 2.00B | 2.08B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.18B | 2.09B | 2.24B | 2.00B | 2.08B |
| Cost of Revenue | 635.50M | 564.20M | 795.50M | 559.30M | 592.20M |
| Gross Profit | 1.54B | 1.52B | 1.45B | 1.44B | 1.49B |
| SG&A Expenses | 882.30M | 846.20M | 838.50M | 809.40M | 807.20M |
| Depreciation & Amortization | 163.40M | 162.10M | 177.70M | 176.50M | 160.60M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.79B | 1.68B | 1.93B | 1.66B | 1.67B |
| Operating Income | 391.00M | 410.80M | 313.40M | 340.30M | 404.00M |
| Income Before Tax | 255.10M | 301.30M | 97.90M | 279.20M | 224.60M |
| Income Tax Expenses | 55.50M | 63.00M | -39.90M | 48.00M | 71.20M |
| Earnings from Continuing Operations | 199.60M | 238.30M | 137.80M | 231.20M | 153.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.30M | -200.00K | 1.50M | -300.00K | -600.00K |
| Net Income | 198.30M | 238.10M | 139.30M | 230.90M | 152.80M |
| EBIT | 391.00M | 410.80M | 313.40M | 340.30M | 404.00M |
| EBITDA | 661.80M | 680.80M | 597.40M | 623.90M | 675.80M |
| EPS Basic | 1.03 | 1.22 | 0.71 | 1.17 | 0.77 |
| Normalized Basic EPS | 1.04 | 1.09 | 0.80 | 0.85 | 1.03 |
| EPS Diluted | 1.03 | 1.22 | 0.71 | 1.16 | 0.77 |
| Normalized Diluted EPS | 1.03 | 1.08 | 0.80 | 0.85 | 1.03 |
| Average Basic Shares Outstanding | 192.20M | 195.00M | 197.20M | 198.10M | 197.90M |
| Average Diluted Shares Outstanding | 192.80M | 195.80M | 198.10M | 198.80M | 198.30M |
| Dividend Per Share | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Payout Ratio | 23.45% | 19.70% | 34.10% | 20.57% | 31.09% |